This is a dilutive emergency capital raise from a micro-cap company with a going-concern risk. The offering has no minimum, so proceeds could be far below the $4.4M estimate. Monitor the closing date and the actual amount raised; if less than $2M, the company may need another financing within weeks. The concurrent warrant repricing adds further dilution. The stock is likely to trade under pressure given the massive potential dilution (up to 33M shares issuable vs. 2.6M outstanding).
Executive Summary
Nuwellis, Inc. filed Amendment No. 2 to its S-1 registration statement for a best-efforts standby equity offering of up to 6,578,948 shares of common stock (or pre-funded warrants in lieu thereof), together with Series C and Series D common warrants, at an assumed combined price of $0.76 per share and accompanying warrants. The offering has no minimum and terminates June 30, 2026; net proceeds are estimated at ~$4.4M if fully subscribed. The company has a $1M market cap, a history of operating losses (net loss of $17.5M in FY2025, accumulated deficit of $316.3M), and only enough cash to fund operations through Q2 2026, making this a dilutive emergency capital raise.
Key Facts
- Best-efforts offering of up to 6,578,948 shares of common stock or pre-funded warrants, with Series C and Series D common warrants, at an assumed combined price of $0.76 per share and accompanying warrants.
- No minimum offering amount; offering terminates June 30, 2026.
- Estimated net proceeds of ~$4.4M if fully subscribed; proceeds used for working capital and general corporate purposes.
- Company had $2.083M in cash as of March 31, 2026, with only enough cash to fund operations through Q2 2026.
- Net loss of $17.5M for FY2025; accumulated deficit of $316.3M as of December 31, 2025.
- Concurrent private transaction to reduce exercise price of up to 3,284,788 outstanding warrants to the public offering price.
- Common warrants exercisable only after stockholder approval and reverse stock split; Series D warrants have zero-cash exercise option providing no additional proceeds.
- Market cap of $1M; stock price $0.76 as of May 27, 2026.
- Two material weaknesses in internal control over financial reporting identified.
- Nasdaq delisting risk: company received deficiency notice for bid price non-compliance in June 2025, subsequently resolved via reverse stock split.
Financial Impact
Maximum gross proceeds of ~$5.0M from the offering; net proceeds ~$4.4M after fees and expenses. Additional ~$5.0M possible if common warrants exercised for cash, but Series D warrants provide zero cash exercise. Company had $2.083M cash as of March 31, 2026, with net loss of $17.5M in FY2025.
Risk Factors
- Offering has no minimum; may raise substantially less than $4.4M, insufficient to fund operations beyond Q2 2026.
- Massive dilution: up to 6.6M shares + 26.3M warrant shares vs. 2.6M shares outstanding.
- Series D warrants provide zero cash exercise, yielding no additional proceeds.
- Common warrants require stockholder approval and reverse stock split to become exercisable; may never be exercisable.
- Company has only $2.083M cash and $17.5M annual net loss; going-concern risk if offering undersubscribed.
- Nasdaq delisting risk remains; stock price at $0.76 near $1.00 minimum bid requirement.
- Two material weaknesses in internal controls could lead to financial reporting errors.
- Litigation risk from E.F. Hutton lawsuit (settled April 2026) and potential future lawsuits.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-1/A Filing (Primary) | 0001140361-26-023964 |
| Document: ny20073226x3_ex10-66.htm | 0001140361-26-023964 |
| Document: ny20073226x3_ex4-4.htm | 0001140361-26-023964 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | 8-K | $0.3221 | awaiting T+20 | — | $3.07 (+851.69%) |
Sep 18, 2026 5w ago | SC 13G/A | $0.8700 $0.5600 | ▼ −35.63% | ▼ −34.72% | $3.07 (+252.34%) |
Sep 17, 2026 5w ago | Press Release | $1.09 $0.5532 | ▲ +49.25% | ▲ +50.45% | $3.07 (−181.23%) |
Aug 27, 2026 8w ago | EFFECT | $0.9900 $0.7915 | ▲ +20.05% | ▲ +19.95% | $3.07 (−209.64%) |
Aug 25, 2026 8w ago | 8-K | $1.01 $0.8700 | ▼ −13.86% | ▼ −15.06% | $3.07 (+203.50%) |
Aug 13, 2026 10w ago | Press Release | $1.30 $0.7740 | ▲ +40.46% | ▲ +38.71% | $3.07 (−135.80%) |
Aug 3, 2026 12w ago | 424B5 | $14.49 $7.13 | ▲ +50.78% | ▲ +52.01% | $3.07 (+78.84%) |
Jul 31, 2026 12w ago | Press Release | $1.74 $0.8889 | ▲ +48.91% | ▲ +51.90% | $3.07 (−76.17%) |
Jun 16, 2026 18w ago | Press Release | $0.1350 $0.0840 | ▼ −37.78% | ▼ −37.83% | $3.07 (+2170.67%) |
Jun 10, 2026 19w ago | 8-K | $0.1520 $0.0869 | ▲ +42.86% | ▲ +46.93% | $3.07 (−1916.71%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers